MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in MoonLake Immunotherapeutics as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- +36 vs. Q2 2023
- Shares held
- 56.3M
- +1.16M (+2.1%) vs. Q2 2023
- Total value
- $3.21B
- +$397.1M (+14.1%) vs. Q2 2023
- New holders
- 47
- 31 more added
- Sold out
- 11
- 26 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 423,387 | $24.1M | 0.00% | +10,118+2.4% | Added |
| Alliancebernstein L.P. | 471,319 | $26.9M | 0.01% | −366,440−43.7% | Reduced |
| RTW Investments, LP | 500,000 | $28.5M | 0.60% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 500,000 | $28.5M | 4.04% | +200,000+66.7% | Added |
| Pictet Asset Management Holding SA | 541,901 | $30.9M | 0.04% | +541,901 | New |
| BlackRock Inc. | 748,878 | $42.7M | 0.00% | +91,344+13.9% | Added |
| Avidity Partners Management LP | 777,172 | $44.3M | 1.78% | +377,172+94.3% | Added |
| Fred Alger Management, LLC | 832,951 | $47.5M | 0.27% | +85,346+11.4% | Added |
| Polar Capital Holdings Plc | 939,012 | $53.5M | 0.40% | −676,377−41.9% | Reduced |
| Federated Hermes, Inc. | 1,084,250 | $61.8M | 0.16% | −85,249−7.3% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,214,723 | $69.2M | 0.05% | +65,914+5.7% | Added |
| Adage Capital Partners GP, L.L.C. | 1,952,703 | $111.3M | 0.25% | +580,375+42.3% | Added |
| Avoro Capital Advisors LLC | 1,999,999 | $114.0M | 1.78% | +274,999+15.9% | Added |
| Citadel Advisors LLC | 2,034,396 | $116.0M | 0.13% | +13,788+0.7% | Added |
| Price T Rowe Associates Inc | 2,117,868 | $120.7M | 0.02% | +174,812+9.0% | Added |
| FMR LLC | 3,397,253 | $193.6M | 0.02% | +19,508+0.6% | Added |
| Cormorant Asset Management, LP | 8,142,100 | $464.1M | 27.07% | 00.0% | Unchanged |
| BVF Inc | 21,751,284 | $1.24B | 33.43% | 00.0% | Unchanged |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −640,000−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −369,615−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −108,450−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −93,789−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −57,347−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −38,617−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −9,500−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −9,421−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |